Novel roles of complement in T effector cell regulation

Immunobiology

Volumn 217, Issue 2, 2012, Pages 216-224

  Heeger, Peter S ^a   Kemper, Claudia ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; C3a; C5a; CD46; Complement; T cell; Transplantation

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPOSITION; COMPLEMENT LECTIN PATHWAY; COMPLEMENT SYSTEM; EFFECTOR CELL; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN METABOLISM; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPECIES INVASION; T LYMPHOCYTE; TH1 CELL;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD46; AUTOIMMUNITY; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, HUMORAL; TH1 CELLS; TRANSPLANTATION IMMUNOLOGY;

EID: 84855296204     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.06.004     Document Type: Review

References (95)

1. + T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells. J. Immunol. 2008, 181:2544-2555.
2. Amsen D., Antov A., Flavell R.A. The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:116-124.
3. Astier A., Trescol-Biemont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 2000, 164:6091-6095.
4. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006, 116:3252-3257.
5. Athman R., Philpott D. Innate immunity via Toll-like receptors and Nod proteins. Curr. Opin. Microbiol. 2004, 7(1):25-32.
6. Bao L., Haas M., Pippin J., Wang Y., Miwa T., Chang A., Minto A.W., Petkova M., Qiao G., Song W.C., Alpers C.E., Zhang J., Shankland S.J., Quigg R.J. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells. J. Clin. Invest. 2009, 119:1264-1274.
7. Baruah P., Dumitriu I.E., Malik T.H., Cook H.T., Dyson J., Scott D., Simpson E., Botto M. C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 2009, 113:3485-3493.
8. Bordet J., Gengou O. Sur l'existence de substances sensibilisatrices dans la plupart des serum antimicrobien. Ann. Inst. Pasteur 1901, 15:289-302.
9. + T cells mediated by CD97. J. Immunol. 2006, 177:1070-1077.
10. Cardone J., Le Friec G., Vantourout P., Roberts A., Fuchs A., Jackson I., Suddason T., Lord G., Atkinson J.P., Cope A., Hayday A., Kemper C. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol 2010, 11(9):862-871.
11. + T cells in mice lacking complement receptors 1 and 2. Scand. J. Immunol. 2009, 70(2):77-84.
12. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5:981-986.
13. Carroll M.C. The complement system in B cell regulation. Mol. Immunol. 2004, 41:141-146.
14. Carter R.H., Spycher M.O., Ng Y.C., Hoffman R., Fearon D.T. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 1988, 141:457-467.
15. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J. Virol. 2004, 78:4385-4388.
16. Chen A., Gaddipati S., Hong Y., Volkman D.J., Peerschke E.I., Ghebrehiwet B. Human T cells express specific sites for C1q: role in T cell activation and proliferation. J. Immunol. 1994, 153:1430-1440.
17. Cope A., Le Friec G., Cardone J., Kemper C. The Th1 lifecycle: molecular control of IFN-γ to IL-10 switching. Trends Immunol. 2011, 10.1016/j.it.2011.03.010.
18. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271:348-350.
19. Esposito A., Suedekum B., Liu J., An F., Lass J., Strainic M.G., Lin F., Heeger P., Medof M.E. Decay accelerating factor is essential for successful corneal engraftment. Am. J. Transplant. 2010, 10:527-534.
20. + T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J. Immunol. 2007, 179:3178-3186.
21. Fang Y., Xu C., Fu Y., Holer V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 1998, 160:5273-5279.
22. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Ann. Rev. Immunol. 1995, 13:127-149.
23. Fernández-Centeno E., de Ojeda G., Rojo J.M., Portolés P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J. Immunol. 2000, 164:4533-4542.
24. Franke, A.,Balschun, T., Karlsen, T.H., Sventoraityte, J., Nikolaus, S., Mayr, G., Domingues, F.S., Albrecht, M., Nothnagel, M., Ellinghaus, D., Sina, C., Onnie, C.M., Weersma, R.K., Stokkers, P.C., Wijmenga, C., Gazouli, M., Strachan, D., McArdle, W.L., Vermeire, S., Rutgeerts, P., Rosenstiel, P., Krawczak, M., Vatn, M.H., IBSEN study group, Mathew, C.G., Schreiber, S., 2008. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40(11), 1319-1323.
25. Gabrysova L., Nicolson K.S., Streeter H.B., Verhagen J., Sabatos-Peyton C.A., Morgan D.J., Wraith D.C. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 2009, 206(8):1755-1767.
26. Gadjeva M., Verschoor A., Brockman M.A., Jezak H., Shen L.M., Knipe D.M., Carroll M.C. Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. J. Immunol. 2002, 169:5489-5495.
27. Gancevici G.G. Role of complement inhibition in topical therapy of muco-cutaneous herpes simplex virus infections. Roum. Arch. Microbiol. Immunol. 1993, 52(4):293-303.
28. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157(2):798-805.
29. Ghannam A., Pernollet M., Fauquert J.L., Monnier N., Ponard D., Villiers M.B., Péguet-Navarro J., Tridon A., Lunardi J., Gerlier D., Drouet C. Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J. Immunol. 2008, 181(7):5158-5166.
30. Ghebrehiwet B., Lim B.L., Kumar R., Feng X., Peerschke E.I. gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection. Immunol. Rev. 2001, 180:65-77.
31. Grossman W.J., Verbsky J.W., Tollefsen B.L., Kemper C., Atkinson J.P., Ley T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004, 104(9):2840-2848.
32. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
33. Gueler F., Rong S., Gwinner W., Mengel M., Bröcker V., Schön S., Greten T.F., Hawlisch H., Polakowski T., Schnatbaum K., Menne J., Haller H., Shushakova N. Complement 5a receptor inhibition improves renal allograft survival. J. Am. Soc. Nephrol. 2008, 19:2302-2312.
34. Hashimoto M., Hirota K., Yoshitomi H., Maeda S., Teradaira S., Akizuki S., Prieto-Martin P., Nomura T., Sakaguchi N., Köhl J., Heyman B., Takahashi M., Fujita T., Mimori T., Sakaguchi S. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 2010, 207:1135-1143.
35. Hawlisch H., Köhl J. Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol. Immunol. 2006, 43:13-21.
36. Heeger P.S., Lalli P.N., Lin F., Valujskikh A., Liu J., Muqim N., Xu Y., Medof M.E. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 2005, 201:1523-1530.
37. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grünig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 1997, 158(7):3311-3316.
38. Inoue N., Ikawa M., Nakanishi T., Matsumoto M., Nomura M., Seya T., Okabe M. Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol. Cell. Biol. 2003, 23(7):2614-2622.
39. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
40. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
41. Kim D.D., Song W.C. Membrane complement regulatory proteins. Clin. Immunol. 2006, 118:127-136.
42. + T cell responses. J. Immunol. 2004, 173:2524-2529.
43. Kopf M., Abel B., Gallimore A., Carroll M., Bachmann M.F. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 2002, 8:373-378.
44. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 1997, 158:4525-4528.
45. Korty P.E., Brando C., Shevach E.M. CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol. 1991, 146:4092-4098.
46. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
47. Lalli P.N., Strainic M.G., Lin F., Medof M.E., Heeger P.S. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating localC5a-induced IL-12 production. J. Immunol. 2007, 179:5793-5802.
48. Lalli P.N., Strainic M.G., Yang M., Lin F., Medof M.E., Heeger P.S. Locally produced C5a binds to T cellexpressedC5aR to enhance effector T-cell expansion by limiting antigeninducedapoptosis. Blood 2008, 112:1759-1766.
49. Larsen G.L., Mitchell B.C., Harper T.B., Henson P.M. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 1982, 126:306-311.
50. Le Friec G., Kemper C. Complement: coming full circle. Arch. Immunol. Ther. Exp. 2009, 57(6):393-407.
51. Le Friec G., Bugeon L., Dallman M., Kemper C. CD46: just a Notch up your complement regulator. Mol. Immunol. 2010, 47(13):2229.
52. Li K., Anderson K.J., Peng Q., Noble A., Lu B., Kelly A.P., Wang N., Sacks S.H., Zhou W. Cyclic AMP plays a critical role in C3areceptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008, 112:5084-5094.
53. Li B., Sallee C., Dehoff M., Foley S., Molina H., Holers V.M. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 1993, 151(8):4295-4305.
54. Li Q., Peng Q., Xing G., Li K., Wang N., Farrar C.A., Meader L., Sacks S.H., Zhou W. Deficiency of C5aR prolongs renal allograft survival. J. Am. Soc. Nephrol. 2010, 21:1344-1353.
55. Liszewski M.K., Post T.W., Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 1991, 9:431-455.
56. Liu J., Miwa T., Hilliard B., Chen Y., Lambris J.D., Wells A.D., Song W.C. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J. Exp. Med. 2005, 201:567-577.
57. Liu J., Lin F., Strainic M.G., An F., Miller R.H., Altuntas C.Z., Heeger P.S., Tuohy V.K., Medof M.E. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J. Immunol. 2008, 180:5882-5889.
58. Lin M., Yin N., Murphy B., Medof M.E., Segerer S., Heeger P.S., Schröppel B. Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 2010, 59(9):2247-2252.
59. Longhi M.P., Harris C.L., Morgan B.P., Gallimore A. Holding T cells in check - a new role for complement regulators?. Trends Immunol. 2006, 27:102-108.
60. + T cell activity in a complement-independent manner. J. Immunol. 2005, 175:7098-7102.
61. Medzhitov R., Janeway C. Innate immunity. N. Engl. J. Med. 2000, 343:338-344.
62. Meiffren G., Flacher M., Azocar O., Rabourdin-Combe C., Faure M. Cutting edge: abortive proliferation of CD46-induced Tr1-like cells due to a defective Akt/Survivin signaling pathway. J. Immunol. 2006, 177(8):4957-4961.
63. Meiler F., Zumkehr J., Klunker S., Rückert B., Akdis C.A., Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 2008, 205(12):2887-2898.
64. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., Chaplin D.D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3357-3361.
65. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
66. Morgan B.P., Harris C.L. Complement Regulatory Proteins 1999, Academic Press, London, UK, Edition.
67. Morgan B.P., Marchbank K.J., Longhi M.P., Harris C.L., Gallimore A.M. Complement: central to innate immunity and bridging to adaptive responses. Immunol. Lett. 2005, 97:171-179.
68. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11(8):674-680.
69. Nakayama Y., Kim S.I., Kim E.H., Lambris J.D., Sandor M., Suresh M. C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection. J. Immunol. 2009, 183(5):2921-2931.
70. O'Garra A., Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 2007, 7(6):425-428.
71. Pavlov V., Raedler H., Yuan S., Leisman S., Kwan W.H., Lalli P.N., Medof M.E., Heeger P.S. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection. J. Immunol. 2008, 181:4580-4589.
72. Pepys M.B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 1974, 140:126-145.
73. Pratt J.R., Basheer S.A., Sacks S.H. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 2002, 8:582-587.
74. Raedler H., Yang M., Lalli P.N., Medof M.E., Heeger P.S. Primed CD8 T-cell responses to allogeneic endothelial cells are controlled by local complement activation. Am. J. Transplant. 2009, 9:1784-1795.
75. Raedler H., Heeger P.S. Complement regulation of T-cell alloimmunity. Curr. Opin. Organ. Transplant. 2011, 16:54-60.
76. Raedler H., Vieyra M., Leisman S., Lakhani P., Kwan W., Yang M., Johnson K., Faas S.J., Tamburini P., Heeger P.S. Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice. Am. J. Transplant. 2011, 10.1111/j.1600-6143.2011.03561.x.
77. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
78. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
79. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., Fontenot J., Castelli L., Ye X., Treuting P., Siewe L., Roers A., Henderson W.R., Muller W., Rudensky A.Y. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28(4):546-558.
80. Sanchez A., Feito M.J., Rojo J.M. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 2004, 34:2439-2448.
81. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10(3):170-181.
82. Sivasankar B., Longhi M.P., Gallagher K.M., Betts G.J., Morgan B.P., Godkin A.J., Gallimore A.M. CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?. J. Immunol. 2009, 182(9):5203-5207.
83. Speidl W.S., Kastl S.P., Hutter R., Katsaros K.M., Kaun C., Bauriedel G., Maurer G., Huber K., Badimon J.J., Wojta J. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J. 2011, 25(1):35-44.
84. + T cells. Immunity 2008, 28:425-435.
85. Suresh M., Molina H., Salvato M.S., Mastellos D., Lambris J.D., Sandor M. Complement component 3 is required for optimal expansion of CD8 T cells during a system viral infection. J. Immunol. 2003, 170:788-794.
86. Verschoor A., Brockman M.A., Gadjeva M., Knipe D.M., Carroll M.C. Myeloid C3 determines induction of humoral responses to peripheral herpes simplex virus infection. J. Immunol. 2003, 171:5363-5371.
87. Vierya, M., Leisman, S., Kwan, W.H., Yang, M., Medof, M.E., Heeger, P.S. Complement regulates CD4 T cell help to CD8 T cells required for allograft rejection. Am. J. Path., in press.
88. Volanakis J.E. Overview of the complement system. The Human Complement System in Health and Disease 1998, 9-32. Marcel Dekker, Inc., New York. 10th ed. J.E. Volanakis, M.M. Frank (Eds.).
89. Wagner C. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol. 2006, 43:643-651.
90. Wagner C., Hansch G.M. Receptors for complement C3 on T-lymphocytes: relics of evolution or functional molecules?. Mol. Immunol. 2006, 43:22-30.
91. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
92. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
93. Werfel T., Kirchhoff K., Wittmann M., Begemann G., Kapp A., Heidenreich F., Götze O., Zwirner J. Activated human T lymphocytes express a functional C3a receptor. J. Immunol. 2000, 165:6599-6605.
94. Wetsel R.A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 1995, 7:48-53.
95. Zaffran Y., Destaing O., Roux A., Ory S., Nheu T., Jurdic P., Rabourdin-Combe C., Astier A.L. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitrogen-activated protein kinase. J. Immunol. 2001, 167:780-6785.